Researchers used a national cohort to describe the characteristics and clinical outcomes of maternity-associated infective endocarditis and to evaluate maternal and fetal outcomes of deliveries complicated by infective endocarditis.

Researchers attempted to determine if medications for opioid use disorder integrated with infectious disease measures can lead to better infectious disease outcomes.

According to the CDC, more than a thousand cases of myocarditis and pericarditis following mRNA COVID-19 vaccination have been reported to the Vaccine Adverse Event Reporting System since April 2021.

Investigators evaluated the impact of interventions including infectious disease consultation, addiction consultation, case management, and medications for opioid use disorder on clinical cure and retention in addiction care for individuals experiencing homelessness.

The American College of Physicians has released guidance on the appropriate use of high-flow nasal oxygen in hospitalized patients with acute respiratory failure.

A team of researchers propose that a population-based study of infective endocarditis in one county in Minnesota provides a unique opportunity to define temporal and seasonal variations in incidence over an extended period.

Investigators assessed prevalence of inflammatory heart disease in professional athletes with prior COVID-19 infections.

Researchers analyzed data from patients with a recent diagnosis of IE hospitalized to see whether PCT, proADM, and copeptin have prognostic value in IE compared with CRP, a known biomarker for IE.

Etiologies and characteristics of infective endocarditis in people who inject vs those do not inject drugs were found to significantly differ.

In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.

This retrospective study aims to shed light on the relationship between splenic infarction and infection.

Case of a 15-year-old African American girl with COVID-19 who developed atrial fibrillation and fulminant myocarditis.

Cutaneous and histopathologic manifestations of COVID-19 infection in a pediatric population are described.

Patients who are hospitalized with COVID-19 and have an elevated vs normal troponin levels were found to be at higher risk for death.

Study authors assessed the association between mortality and age, history of cardiac surgery, and other risk factors in patients undergoing surgery for infective endocarditis.

Ertapenem and cefazolin combination therapy was studied to assess use as salvage therapy for persistent bacteremia against a MSSA blood-stream isolate.

Researchers developed a microsimulation model of the natural history of injection opioid use to assess long-term infective endocarditis mortality associated with injection opioid use in the United States.

Researchers assessed the serious infection risk for denosumab vs alendronate in real-world practice.

The rate of acute cardiovascular events was found to be high in adults hospitalized with influenza.

The new doses of Vanco Ready include 150mL, 250mL, and 350mL premixed bags containing 750mg, 1.25g, and 1.75g of vancomycin, respectively.

Investigators assessed patients who hospitalized with microbial S aureus bacteremia to determine the most meaningful cutoff point to define S aureus persistent bacteremia.

Eight weeks of treatment with glecaprevir/pibrentasvir is both efficacious and well tolerated in treatment-naive patients with HCV.

SARS-CoV-2 was detected in the myocardium of patients who had died from COVID-19.

Trends in infective endocarditis microbiology are of clinical concern and require further study and additional data.

New clinical practice guidelines for the treatment of nontuberculous mycobacterial pulmonary disease were published by leading respiratory medicine and infectious disease societies.

A great percentage of patients with pulmonary valve infective endocarditis were found to require surgical management.

Treatment with daptomycin for bacteremia caused by methicillin-resistant Staphylococcus aureus complicated by septic pulmonary emboli was found to have a success rate comparable to daptomycin-ceftaroline fosamil.

Treatment with the thrombin inhibitor dabigatran was associated with a decreased incidence of Staphylococcus aureus bacteremia compared with treatment with the factor Xa inhibitors rivaroxaban and apixaban.

A team of investigators reviewed data from institutions within the VA healthcare system to assess the ability of 2 algorithms to identify patients with intravenous drug use-associated infective endocarditis.

Members of the ACC’s Sports & Exercise Cardiology Council, with input from national leaders in sports cardiology, provided a consensus expert opinion clinical framework on return to play in the era of COVID-19.